Komentář k článku: Linezolid a terapeutické monitorování: Nastal čas pro rutinní TDM?

Investor logo
Title in English Comment on the article: Linezolid and therapeutic drug monitoring: Is it time for routine TDM?
Authors

GRÁC Martin Róbert SUK Pavel RYCHLÍČKOVÁ Jitka

Year of publication 2026
Type Peer-reviewed scientific article
Magazine / Source Klinicka Farmakologie a Farmacie
MU Faculty or unit

Faculty of Medicine

Citation
web https://www.klinickafarmakologie.cz/artkey/far-202601-0011_komentar_k_clanku_linezolid_a_terapeuticke_monitorovani_nastal_cas_pro_rutinni_tdm.php
Doi https://doi.org/10.36290/far.2025.075
Keywords linezolid; therapeutic drug monitoring; continuous infusion; dosage; indication
Description Commentary on the article: Linezolid and therapeutic drug monitoring: Is it time for routine TDM? This commentary concerns the addition of an off-label indication for linezolid, its dosage and the benefits of therapeutic monitoring.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info